Coherent price target raised to $110 from $109 at Raymond James
Raymond James raised the firm’s price target on Coherent (COHR) to $110 from $109 and keeps an Outperform rating on the shares. Coherent’s Q2 ...
Boston Scientific price target raised to $122 from $119 at Raymond James
Raymond James analyst Jayson Bedford raised the firm’s price target on Boston Scientific (BSX) to $122 from $119 and keeps a Strong Buy rating ...